REBECCA NORTHINGTON: Open Payments
NPI 1376645697 · FULTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,457 in 96 payments from 17 companies in 2025. Trend: 2023 $1,171 · 2024 $1,293 · 2025 $1,457
Food & beverage: $1,457
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $215 |
| Otsuka America Pharmaceutical, Inc. | 9 | $194 |
| Amgen Inc. | 13 | $193 |
| Novo Nordisk Inc | 11 | $173 |
| PFIZER INC. | 10 | $156 |
| Lilly USA, LLC | 8 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $99 |
| Xeris Pharmaceuticals, Inc. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
Products named: REXULTI, VRAYLAR, MOUNJARO, Kerendia, NURTEC ODT, EVENITY, OTEZLA, Wegovy.
Industry payments across MS — which companies pay providers there.
